Opus Genetics, Inc.
IRD
$0.865
$0.00430.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.30M | 3.87M | 1.11M | 1.71M | 1.69M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.30M | 3.87M | 1.11M | 1.71M | 1.69M |
| Cost of Revenue | 7.78M | 8.75M | 280.00K | 4.74M | 4.70M |
| Gross Profit | -3.48M | -4.88M | 832.00K | -3.03M | -3.01M |
| SG&A Expenses | 7.27M | 2.90M | 3.36M | 4.68M | 3.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.33M | 11.88M | 9.44M | 9.42M | 7.12M |
| Operating Income | -10.03M | -8.01M | -8.33M | -7.71M | -5.43M |
| Income Before Tax | -35.14M | -7.53M | -7.77M | -7.11M | -4.80M |
| Income Tax Expenses | -- | -- | -- | -- | -2.00K |
| Earnings from Continuing Operations | -35.14M | -7.53M | -7.77M | -7.11M | -4.80M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.14M | -7.53M | -7.77M | -7.11M | -4.80M |
| EBIT | -10.03M | -8.01M | -8.33M | -7.71M | -5.43M |
| EBITDA | -10.03M | -8.01M | -8.33M | -7.71M | -5.43M |
| EPS Basic | -1.16 | -0.29 | -0.30 | -0.29 | -0.21 |
| Normalized Basic EPS | -0.15 | -0.18 | -0.19 | -0.18 | -0.13 |
| EPS Diluted | -1.16 | -0.29 | -0.30 | -0.29 | -0.21 |
| Normalized Diluted EPS | -0.15 | -0.18 | -0.19 | -0.18 | -0.13 |
| Average Basic Shares Outstanding | 30.36M | 26.15M | 25.83M | 24.52M | 22.99M |
| Average Diluted Shares Outstanding | 30.36M | 26.15M | 25.83M | 24.52M | 22.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |